Compare
Hims & Hers Health, Inc. vs LifeMD, Inc. vs SBC Medical Group Holdings Inc vs Cardiff Lexington Corp
| Latest fiscal year | Hims & Hers Health, Inc. HIMS | LifeMD, Inc. LFMD | SBC Medical Group Holdings Inc SBC | Cardiff Lexington Corp CDIX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $2.35B | $194.06M | $173.61M | $11.54M |
| Revenue growth (YoY) | +59.0% | +25.3% | -15.5% | +39.5% |
| Gross margin | 73.8% | 85.7% | 73.3% | 62.5% |
| Operating margin | 4.5% | -4.0% | 38.9% | 9.5% |
| Net margin | 5.5% | 7.4% | 29.4% | -47.7% |
| Net income | $128.37M | $14.35M | $50.99M | -$5.51M |
| EPS (Diluted) | $0.51 | $0.25 | $0.50 | n/a |
| Operating cash flow | $300.01M | $8.28M | $24.67M | -$2.85M |
| Free cash flow | $57.41M | $6.41M | $23.27M | n/a |
| Cash & equivalents | $228.62M | n/a | $163.77M | n/a |
| Total assets | $2.15B | $70.41M | $380.45M | $29.09M |
| Total liabilities | $1.61B | $47.25M | $117.14M | $26.01M |
| Shareholders' equity | $540.93M | $23.16M | $248.28M | -$2.47M |
| Return on year-end equity | 23.7% | 62.0% | 20.5% | n/a |
| Shares outstanding | n/a | 46.66M | 102.58M | 13.70M |
Revenue, most recent five fiscal years
| Fiscal year | Hims & Hers Health, Inc. | LifeMD, Inc. | SBC Medical Group Holdings Inc | Cardiff Lexington Corp |
|---|---|---|---|---|
| Latest | $2.35B Ended 2025-12-31 | $194.06M Ended 2025-12-31 | $173.61M Ended 2025-12-31 | $11.54M Ended 2025-12-31 |
| 1 year earlier | $1.48B Ended 2024-12-31 | $154.82M Ended 2024-12-31 | $205.42M Ended 2024-12-31 | $8.27M Ended 2024-12-31 |
| 2 years earlier | $872.00M Ended 2023-12-31 | $152.55M Ended 2023-12-31 | $193.54M Ended 2023-12-31 | $11.85M Ended 2023-12-31 |
| 3 years earlier | $526.92M Ended 2022-12-31 | $119.03M Ended 2022-12-31 | n/a | $10.69M Ended 2022-12-31 |
| 4 years earlier | $271.88M Ended 2021-12-31 | $92.88M Ended 2021-12-31 | n/a | $9.88M Ended 2021-12-31 |